Background Candidemia remains a major cause of morbidity and mortality in the health care
setting, and the epidemiology of Candida infection is changing. Methods Clinical and …

BACKGROUND: Between May 2003 and April 2005, a population‐based surveillance of
Candida bloodstream infections was conducted in Quebec. A total of 453 episodes of …

Candida is the fourth most common cause of nosocomial bloodstream infections (BSI), being
Candida albicans the most common species. This study evaluated the distribution of …

ABSTRACT A retrospective survey of candidaemia between 2001 and 2006 was performed
at the University Hospital of Vienna, a 2200-bed centre with large organ transplantation and …

Background Candida species represent the fourth leading cause of nosocomial bloodstream
infections (BSI) worldwide. However, candidaemia rates and species involved vary …

Objective: To assess changes in the epidemiology of nosocomial candidemia in the post-
fluconazole era among hospitalized patients using a case–control study design. Design …

Background Infection represents a frequent complication among patients in Intensive Care
Units (ICUs) and mortality is high. In particular, the incidence of fungal infections, especially …

The primary aim of this study was to collect national epidemiological data on candidaemia
and to determine the reporting time of species identification and antifungal susceptibility in …

Thirty-seven episodes of hospital-acquired candidaemia, which occurred over a two-year
period, were reviewed. The predominant risk factors were previous antibiotic therapy …

Candida spp. are an increasing cause of bloodstream infections, and are associated with
high morbidity and mortality in both neutropenic and non-neutropenic critically ill patients …